Rev. Bras. Hematol. Hemoter. vol.34 número5

Results of the randomized international FAB/ LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the

Methods: In an attempt to ascertain the impact of systematic nutritional care on patients submitted to allogeneic hematopoietic stem cell transplantation, the present study

Overall, genetic guidance and laboratory screening of the family turned out to be effective educational and preventive measures as the majority of patients improved their level

Evaluation instruments included the 2-minute walking test to evaluate gait performance with assessment of the oxygen saturation, heart rate and Borg Scale before and after the

Measurement of the hemoglobin (g/dL) and ferritin (ng/dL) levels were also evaluated according to gender and compared between the Anemic and Non-anemic Groups using

The irst cycle of treatment was modiied in patients with severe clinical events at diagnosis, such as a high tumor burden associated with pleural and peritoneal effusions,

Failure to achieve a complete hematologic response at the time of a major cytogenetic response with second-generation tyrosine kinase inhibitors is associated with a poor

Other scenarios in which voriconazole is frequently used include primary prophylaxis of high risk patients (allogeneic HSCT or even AML patients in induction remission),